New drug programme for Auckland inmates

Published October 13, 2010

New drug programme for Auckland inmates
A group of Auckland Prison inmates have this week started a three-month intensive substance abuse programme in a new drug treatment unit.The unit, the first of its kind in greater Auckland, will not be officially opened until…
Read more on The New Zealand Herald

Sales of Merck’s telcagepant and CoLucid’s lasmiditan in world’s major markets to reach .3 billion in 2019
Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that two first-in-class agents — Merck’s telcagepant and CoLucid’s lasmiditan — will earn combined sales of approximately $ 1.3 billion in 2019 in the United States, France, Germany, Italy, Spain, United Kingdom and Japan.
Read more on News-Medical-Net

Facility helps offenders uncover talents once masked by violence
BY BRIDGET THARP BLADE STAFF WRITER
Read more on The Toledo Blade